Every month we check 4 pharmaceutical industry regulatory bodies (the FDA, European Commission, MHRA, and HPRA) and bring together their news into one handy update.
Round up of Regulatory News from March 2026
FDA news from March 2026
- 1 March – FDA Grants Third Approval Under the National Priority Voucher Program
- 9 March – FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable
- 10 March – FDA Approves First Treatment for Patients with Cerebral Folate Transport Deficiency
- 11 March – FDA Launches New Adverse Event Look-Up Tool
- 18 March – FDA Releases Draft Guidance on Alternatives to Animal Testing in Drug Development
- 19 March – FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutide
- 25 March – FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome
- 26 March – FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I
European Commission news from March 2026
MHRA news from March 2026
- 5 March – UK sets out world‑leading pathway for space‑manufactured drugs
- 12 March – MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
- 17 March – Patients to get new medicines up to six months sooner under new joint MHRA-NICE approval process
- 24 March – MHRA action boosts drive to phase out animal testing
HPRA news from March 2026
References
European Commission – https://health.ec.europa.eu/medicinal-products/latest-updates_en
FDA – https://www.fda.gov/news-events/fda-newsroom/press-announcements
HPRA – https://www.hpra.ie/news-events/news
MHRA – https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
About the Author
Claire Wilson
Content Marketing and Career Coaching
Claire runs GetReskilled’s Advanced Career Coaching Programme – our specially devised job hunting course that helps our trainees take that final step into employment by leading them through the job hunting process. She is extremely enthusiastic about helping people reach their final goal of employment in their new career path.
Claire has a BSc (Hons) in Medical Biology from Edinburgh University and spent 7 years working in the pharmaceutical and medical device industries.
Post Your Comments Below